Oxford BioDynamics (Oxford BioDynamics) Capex-to-Operating-Income : 0.00 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Oxford BioDynamics's Capital Expenditure for the six months ended in Sep. 2023 was $-0.56 Mil. Its Operating Income for the six months ended in Sep. 2023 was $-6.70 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Oxford BioDynamics Capex-to-Operating-Income Historical Data

The historical data trend for Oxford BioDynamics's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Capex-to-Operating-Income Chart

Oxford BioDynamics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Capex-to-Operating-Income

Get a 7-Day Free Trial

Oxford BioDynamics Semi-Annual Data
	Sep13	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Capex-to-Operating-Income	Get a 7-Day Free Trial														-	-	-	-	-

Competitive Comparison of Oxford BioDynamics's Capex-to-Operating-Income

For the Biotechnology subindustry, Oxford BioDynamics's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Capex-to-Operating-Income falls into.

Oxford BioDynamics Capex-to-Operating-Income Calculation

Oxford BioDynamics's Capex-to-Operating-Income for the fiscal year that ended in Sep. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.886)	/	-12.584
	=	N/A

Oxford BioDynamics's Capex-to-Operating-Income for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.563)	/	-6.696
	=	N/A

Oxford BioDynamics (OTCPK:OXBOF) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Oxford BioDynamics Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics (Oxford BioDynamics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

OBD:UK

Address

Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.